Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 786 GBX 0.56% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Genus PLC?
Write Note

Genus PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genus PLC
Research & Development Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Research & Development
-$124.4m
CAGR 3-Years
-137%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Research & Development
-ÂŁ117m
CAGR 3-Years
-105%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Research & Development
-$122.3m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Research & Development
-$167.9m
CAGR 3-Years
-59%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Research & Development
-ÂŁ163.5m
CAGR 3-Years
-30%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

Back to Top